Vir Biotechnology, Inc. VIR Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Vir Biotechnology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vir Biotechnology, Inc.'s common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vir Biotechnology, Inc.'s common stock?
- Vir Biotechnology, Inc. (VIR) reported common stock of 300M in Q1 2026.
- How has Vir Biotechnology, Inc.'s common stock changed year-over-year?
- Vir Biotechnology, Inc.'s common stock decreased by 0.0% year-over-year, from 300M to 300M.
- What is the long-term trend for Vir Biotechnology, Inc.'s common stock?
- Over 5 years (2020 to 2025), Vir Biotechnology, Inc.'s common stock has grown at a 645.8% compound annual growth rate (CAGR), from 13K to 300M.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).